<?xml version="1.0" encoding="UTF-8"?>
<p>CBDA reduced COX2 expression in triple-negative MDA-MB-231 human breast cancer cell with a concentration of 5 µM by abrogating the transcriptional activities of both activator protein-I (AP-I) and peroxisome proliferator-activated receptor PPARβ/δ [
 <xref rid="B63-ijms-21-09049" ref-type="bibr">63</xref>]. CBDA inhibited human breast cancer cell metastasis by suppressing COX2 and proto-oncogene c-Fos expression and upregulating the expression of SHARP1(1.72-fold), a suppressor of breast cancer metastasis [
 <xref rid="B63-ijms-21-09049" ref-type="bibr">63</xref>,
 <xref rid="B64-ijms-21-09049" ref-type="bibr">64</xref>,
 <xref rid="B65-ijms-21-09049" ref-type="bibr">65</xref>,
 <xref rid="B66-ijms-21-09049" ref-type="bibr">66</xref>].
</p>
